Reckitt Benckiser Group plc (OTCMKTS:RBGLY – Get Free Report) announced a dividend on Saturday, March 15th, NASDAQ Dividends reports. Stockholders of record on Friday, April 11th will be paid a dividend of 0.2909 per share on Thursday, June 5th. The ex-dividend date is Friday, April 11th. This is a 51.9% increase from Reckitt Benckiser Group’s previous dividend of $0.19.
Reckitt Benckiser Group Stock Performance
Shares of OTCMKTS:RBGLY traded down $0.23 on Friday, hitting $13.33. The company had a trading volume of 321,920 shares, compared to its average volume of 311,617. The company has a quick ratio of 0.47, a current ratio of 0.69 and a debt-to-equity ratio of 0.97. Reckitt Benckiser Group has a 52-week low of $10.24 and a 52-week high of $14.10. The business has a 50 day moving average of $12.98 and a 200 day moving average of $12.47.
Wall Street Analyst Weigh In
RBGLY has been the topic of several recent research reports. HSBC upgraded Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a research report on Wednesday, December 11th. Royal Bank of Canada reiterated an “outperform” rating on shares of Reckitt Benckiser Group in a research report on Friday, March 7th. Barclays downgraded Reckitt Benckiser Group from an “overweight” rating to an “equal weight” rating in a research report on Tuesday, February 4th. Finally, Hsbc Global Res upgraded Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, December 11th. Three research analysts have rated the stock with a hold rating, two have assigned a buy rating and three have assigned a strong buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Buy”.
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Further Reading
- Five stocks we like better than Reckitt Benckiser Group
- What is a Low P/E Ratio and What Does it Tell Investors?
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- Stock Analyst Ratings and Canadian Analyst Ratings
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- What Are the FAANG Stocks and Are They Good Investments?
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.